FDA.reportPublic FDA data

POVIDONE K30

Substance profile for UNII U725QWY32X, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Matched legacy or normalized UNII 390RMW2PEQ.

Substance Identity#

UNII
U725QWY32X
Preferred term
POVIDONE K30
Registry number
9003-39-8
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Polymer substance not supported

Chemical And Database Identifiers#

RxCUI
1297406
PubChem
0
NCIt
C82262
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm1297406https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1297406
NCI ThesaurusC82262https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C82262
FDA Substance Registration SystemU725QWY32Xhttps://precision.fda.gov/uniisearch/srs/unii/U725QWY32X

Legacy UNII Aliases#

Legacy UNII, Term, Last update table
Legacy UNIITermLast update
U725QWY32XPOVIDONE K302019-03-18 19:36:14

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
POVIDONE K30INACTIVE INGREDIENTU725QWY32XThese highlights do not include all the information needed to use Meloxicam Tablets, USP safely and effectively. See full prescribing information for Meloxicam Tablets, USP. MELOXICAM Tablets, USP for oral use Initial U.S. Approval: 20005
POVIDONE K30INACTIVE INGREDIENTU725QWY32XATENOLOL1
POVIDONE K30INACTIVE INGREDIENTU725QWY32XETODOLAC3
POVIDONE K30INACTIVE INGREDIENTU725QWY32XATENOLOL1
POVIDONE K30INACTIVE INGREDIENTU725QWY32XMetformin Hydrochloride Tablets USP Rx Only3
POVIDONE K30INACTIVE INGREDIENTU725QWY32XCARISOPRODOL2
POVIDONE K30INACTIVE INGREDIENTU725QWY32XTRAMADOL HYDROCHLORIDE3
POVIDONE K30INACTIVE INGREDIENTU725QWY32XThese highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP. OMEPRAZOLE Delayed-Release Capsules, USP, for oral use INITIAL U.S. APPROVAL: 19894
POVIDONE K30INACTIVE INGREDIENTU725QWY32XThese highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP. OMEPRAZOLE Delayed-Release Capsules, USP, for oral use INITIAL U.S. APPROVAL: 19892
POVIDONE K30INACTIVE INGREDIENTU725QWY32XMETFORMIN HYDROCHLORIDE TABLETS USP, 500 mg, 850 mg, and 1000 mg 1048 1049 7214 Rx only2
POVIDONE K30INACTIVE INGREDIENTU725QWY32XThese highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP . OMEPRAZOLE Delayed-Release Capsules, USP , for oral use INITIAL U.S. APPROVAL: 198915
POVIDONE K30INACTIVE INGREDIENTU725QWY32XThese highlights do not include all the information needed to use levetiracetam tablets safely and effectively. See full prescribing information for levetiracetam tablets USP. Levetiracetam Tablets USP for Oral Use Initial U.S. Approval: 19992
POVIDONE K30INACTIVE INGREDIENTU725QWY32XVENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES USP 7384 7385 7386 Rx only7
POVIDONE K30INACTIVE INGREDIENTU725QWY32XThese highlights do not include all the information needed to use duloxetine delayed-release capsules USP safely and effectively. See full prescribing information for duloxetine delayed-release capsules USP. DULOXETINE delayed-release capsules USP for oral use Initial U.S. Approval: 20042
povidone k30INACTIVE INGREDIENTU725QWY32XDiclofenac sodium and misoprostol delayed-release tablets3
POVIDONE K30INACTIVE INGREDIENTU725QWY32XThese highlights do not include all the information needed to use carvedilol safely and effectively. See full prescribing information for carvedilol tablets, USP. Carvedilol Tablets, USP Initial U.S. Approval: 19951001
POVIDONE K30INACTIVE INGREDIENTU725QWY32XThese highlights do not include all the information needed to use amlodipine besylate and benazepril hydrochloride capsules safely and effectively. See full prescribing information for amlodipine besylate and benazepril hydrochloride capsules. AMLODIPINE besylate and BENAZEPRIL hydrochloride capsules for oral use Initial U.S. Approval: 19951000
Povidone K30INACTIVE INGREDIENTU725QWY32XThese highlights do not include all the information needed to use Meloxicam Tablets, USP safely and effectively. See full prescribing information for Meloxicam Tablets, USP. Meloxicam Tablets, USP Initial U.S. Approval: 200010
POVIDONE K30INACTIVE INGREDIENTU725QWY32XClarithromycin Tablets, USP R X only To reduce the development of drug-resistant bacteria and maintain the effectiveness of clarithromycin and other antibacterial drugs, clarithromycin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.9
POVIDONE K30INACTIVE INGREDIENTU725QWY32XCITALOPRAM TABLETS USP Rx only2
POVIDONE K30INACTIVE INGREDIENTU725QWY32XTheophylline Extended-Release Tablets Rx only2
POVIDONE K30INACTIVE INGREDIENTU725QWY32X489c5c7d-75e3-4b98-b7d5-3c61e2f98adf2
POVIDONE K30INACTIVE INGREDIENTU725QWY32XLITHIUM CARBONATE Tablets USP, LITHIUM CARBONATE Capsules USP, LITHIUM Oral Solution USP2
POVIDONE K30INACTIVE INGREDIENTU725QWY32XVenlafaxine Hydrochloride Extended-Release Capsules Rx only3
POVIDONE K30INACTIVE INGREDIENTU725QWY32X6175419e-9faa-4b23-bc29-24f24e9588802
POVIDONE K30INACTIVE INGREDIENTU725QWY32XThese highlights do not include all the information needed to use Omeprazole safely and effectively. See full prescribing information for Omeprazole. Omeprazole (Omeprazole) CAPSULE for ORAL use. Initial U.S. Approval: 20133
POVIDONE K30INACTIVE INGREDIENTU725QWY32XMetformin Hydrochloride Tablets USP3
POVIDONE K30INACTIVE INGREDIENTU725QWY32XThese highlights do not include all the information needed to use lamotrigine tablets safely and effectively. See full prescribing information for lamotrigine tablets. LAMOTRIGINE tablets for oral use Initial U.S. Approval: 199410
POVIDONE K30INACTIVE INGREDIENTU725QWY32XAlprazolam Tablets, USP CIV2
Povidone K30INACTIVE INGREDIENTU725QWY32XThese highlights do not include all the information needed to use Meloxicam Tablets, USP safely and effectively. See full prescribing information for Meloxicam Tablets, USP. MELOXICAM Tablets, USP Initial U.S. Approval: 20002
POVIDONE K30INACTIVE INGREDIENTU725QWY32XTRANDOLAPRIL TABLETS 7325 7326 7327 Rx only4
POVIDONE K30INACTIVE INGREDIENTU725QWY32XSulindac Tablets USP, 150 mg and 200 mg Rx only1
POVIDONE K30INACTIVE INGREDIENTU725QWY32XAtovaquone and Proguanil Hydrochloride Tablets1
POVIDONE K30INACTIVE INGREDIENTU725QWY32XThese highlights do not include all the information needed to use levetiracetam tablets safely and effectively. See full prescribing information for levetiracetam tablets USP. Levetiracetam Tablets USP for Oral Use Initial U.S. Approval: 19991
POVIDONE K30INACTIVE INGREDIENTU725QWY32XThese highlights do not include all the information needed to use ziprasidone safely and effectively. See full prescribing information for ziprasidone. Ziprasidone Hydrochloride Capsules for Oral use Initial U.S. Approval: 20013
Povidone K30INACTIVE INGREDIENTU725QWY32XThese highlights do not include all the information needed to use Meloxicam Tablets, USP safely and effectively. See full prescribing information for Meloxicam Tablets, USP. MELOXICAM Tablets, USP Initial U.S. Approval: 20002
POVIDONE K30INACTIVE INGREDIENTU725QWY32Xa1741a0b-3d4c-42dc-880d-a06e96cce9ef2
POVIDONE K30INACTIVE INGREDIENTU725QWY32XHaloperidol Tablets, USP2
POVIDONE K30INACTIVE INGREDIENTU725QWY32XDrug Facts3
POVIDONE K30INACTIVE INGREDIENTU725QWY32XThese highlights do not include all the information needed to use Pramipexole Dihydrochloride Tablets safely and effectively. See full prescribing information for pramipexole dihydrochloride tablets. Pramipexole Dihydrochloride Tablets for oral administration Initial U.S. Approval: 19972
POVIDONE K30INACTIVE INGREDIENTU725QWY32XVENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES 7384 7385 7386 Rx only6
POVIDONE K30INACTIVE INGREDIENTU725QWY32XDrug Facts1
POVIDONE K30INACTIVE INGREDIENTU725QWY32XThese highlights do not include all the information needed to use carvedilol safely and effectively. See full prescribing information for carvedilol tablets, USP. Carvedilol Tablets, USP Initial U.S. Approval: 19951000
POVIDONE K30INACTIVE INGREDIENTU725QWY32XDRUG FACTS1
POVIDONE K30INACTIVE INGREDIENTU725QWY32XThese highlights do not include all the information needed to use Tramadol Hydrochloride Extended-Release safely and effectively. See full prescribing information for Tramadol Hydrochloride Extended-Release. Tramadol Hydrochloride Extended-Release (tramadol hydrochloride) Extended-Release Capsules Initial U.S. Approval: 19951
POVIDONE K30INACTIVE INGREDIENTU725QWY32XThese highlights do not include all the information needed to use irbesartan and hydrochlorothiazide tablets USP safely and effectively. See full prescribing information for irbesartan and hydrochlorothiazide tablets USP. IRBESARTAN and HYDROCHLOROTHIAZIDE tablets USP for oral use Initial U.S. Approval: 19974
POVIDONE K30INACTIVE INGREDIENTU725QWY32XImipramine Hydrochloride Tablets USP1
POVIDONE K30INACTIVE INGREDIENTU725QWY32XCarisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 19594
POVIDONE K30INACTIVE INGREDIENTU725QWY32XThese highlights do not include all the information needed to use Tramadol Hydrochloride Extended-Release safely and effectively. See full prescribing information for Tramadol Hydrochloride Extended-Release. Tramadol Hydrochloride Extended-Release (tramadol hydrochloride) Extended-Release Capsules Initial U.S. Approval: 19952
POVIDONE K30INACTIVE INGREDIENTU725QWY32XDrug Facts5
POVIDONE K30INACTIVE INGREDIENTU725QWY32XPHOSPHA 250™ NEUTRAL Supplies 250 mg of phosphorus per tablet2
POVIDONE K30INACTIVE INGREDIENTU725QWY32Xd54a97d5-3664-4ca5-bffd-8366c7255b738
POVIDONE K30INACTIVE INGREDIENTU725QWY32XMetformin Hydrochloride Tablets USP Rx Only2
POVIDONE K30INACTIVE INGREDIENTU725QWY32XSKIN DEFENSE MAKEUP SPF-152
POVIDONE K30INACTIVE INGREDIENTU725QWY32XFACE PROTECTOR SPF 403
POVIDONE K30INACTIVE INGREDIENTU725QWY32XThese highlights do not include all the information needed to use levetiracetam safely and effectively. See full prescribing information for levetiracetam. Levetiracetam Tablets, USP Initial U.S. Approval: 19997
POVIDONE K30INACTIVE INGREDIENTU725QWY32XGlycopyrrolate Tablets, USP Rx Only Revised 02/114
POVIDONE K30INACTIVE INGREDIENTU725QWY32XThese highlights do not include all the information needed to use carvedilol safely and effectively. See full prescribing information for carvedilol tablets, USP. Carvedilol Tablets, USP Initial U.S. Approval: 19951
POVIDONE K30INACTIVE INGREDIENTU725QWY32XMefloquine Hydrochloride Tablets Rev. 07/111
POVIDONE K30INACTIVE INGREDIENTU725QWY32XThese highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 19593
POVIDONE K30INACTIVE INGREDIENTU725QWY32XThese highlights do not include all the information needed to use carvedilol safely and effectively. See full prescribing information for carvedilol tablets, USP. Carvedilol Tablets, USP Initial U.S. Approval: 19953
povidone K30INACTIVE INGREDIENTU725QWY32XARTHROTEC ® (diclofenac sodium/misoprostol) Tablets5
POVIDONE K30INACTIVE INGREDIENTU725QWY32XBENAZEPRIL HYDROCHLORIDE TABLETS USP, 5 mg, 10 mg, 20 mg and 40 mg 5124 5125 5126 5127 Rx only3
POVIDONE K30INACTIVE INGREDIENTU725QWY32XAlprazolam Tablets, USP CIV2
POVIDONE K30INACTIVE INGREDIENTU725QWY32XDrug Facts3
POVIDONE K30INACTIVE INGREDIENTU725QWY32XSertraline Hydrochloride Tablets Rx Only Rev. 09/113
POVIDONE K30INACTIVE INGREDIENTU725QWY32XSertraline Hydrochloride Tablets Rx Only Rev. 09/112
POVIDONE K30INACTIVE INGREDIENTU725QWY32XSenophylline8
POVIDONE K30INACTIVE INGREDIENTU725QWY32XThese highlights do not include all the information needed to use carvedilol safely and effectively. See full prescribing information for carvedilol tablets, USP. Carvedilol Tablets, USP Initial U.S. Approval: 19952
POVIDONE K30INACTIVE INGREDIENTU725QWY32XHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use anastrozole tablets safely and effectively. See full prescribing information for anastrozole tablets. Initial U.S. Approval6
POVIDONE K30INACTIVE INGREDIENTU725QWY32X7591bed3-77ef-4074-a86f-7dcbd8070ec62
POVIDONE K30INACTIVE INGREDIENTU725QWY32XHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use anastrozole tablets safely and effectively. See full prescribing information for anastrozole tablets. Initial U.S. Approval7
POVIDONE K30INACTIVE INGREDIENTU725QWY32XINVIRASE ® (saquinavir mesylate) CAPSULES and TABLETS3
POVIDONE K30INACTIVE INGREDIENTU725QWY32XSertraline Hydrochloride Tablets2
POVIDONE K30INACTIVE INGREDIENTU725QWY32XHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use anastrozole tablets safely and effectively. See full prescribing information for anastrozole tablets. Initial U.S. Approval2
POVIDONE K30INACTIVE INGREDIENTU725QWY32XP LAX TABLETS DR, 5 mg-SUGAR COATED: PINK1
POVIDONE K30INACTIVE INGREDIENTU725QWY32XY LAX TABLETS DR, 5 mg-SUGAR COATED: YELLOW1
POVIDONE K30INACTIVE INGREDIENTU725QWY32XLITHIUM CARBONATE Tablets USP, LITHIUM CARBONATE Capsules USP, LITHIUM Oral Solution USP2
POVIDONE K30INACTIVE INGREDIENTU725QWY32XDIVALPROEX SODIUM DELAYED-RELEASE TABLETS4
POVIDONE K30INACTIVE INGREDIENTU725QWY32XTAMOXIFEN CITRATE TABLETS USP, 10 mg and 20 mg (base) 0784 0782 Rx only2
POVIDONE K30INACTIVE INGREDIENTU725QWY32XETHAMBUTOL HYDROCHLORIDE TABLETS, USP3
POVIDONE K30INACTIVE INGREDIENTU725QWY32XBuprenorphine hydrochloride 8mg1002
POVIDONE K30INACTIVE INGREDIENTU725QWY32XNifedipine Capsules2
POVIDONE K30INACTIVE INGREDIENTU725QWY32XGLIMEPIRIDE TABLET [MICRO LABS LIMITED]91224
POVIDONE K30INACTIVE INGREDIENTU725QWY32XCARISOPRODOL TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3970
POVIDONE K30INACTIVE INGREDIENTU725QWY32XSERTRALINE HYDROCHLORIDE TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3958
POVIDONE K30INACTIVE INGREDIENTU725QWY32XALPRAZOLAM TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3866
povidone K30INACTIVE INGREDIENTU725QWY32XSUBOXONE (BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE) TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3832
povidone K30INACTIVE INGREDIENTU725QWY32XARTHROTEC (DICLOFENAC SODIUM AND MISOPROSTOL) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3585
POVIDONE K30INACTIVE INGREDIENTU725QWY32XVENLAFAXINE HYDROCHLORIDE TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3320
Povidone K30INACTIVE INGREDIENTU725QWY32XMELOXICAM TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3280
POVIDONE K30INACTIVE INGREDIENTU725QWY32XFLECTOR (DICLOFENAC EPOLAMINE ) PATCH [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3142
POVIDONE K30INACTIVE INGREDIENTU725QWY32XSUBOXONE (BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE) TABLET [BRYANT RANCH PREPACK]1004
POVIDONE K30INACTIVE INGREDIENTU725QWY32XIRBESARTAN TABLET [BRYANT RANCH PREPACK]1002
POVIDONE K30INACTIVE INGREDIENTU725QWY32XTRAMADOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK]1002
POVIDONE K30INACTIVE INGREDIENTU725QWY32XASPIRIN TABLET [BRYANT RANCH PREPACK]1001
POVIDONE K30INACTIVE INGREDIENTU725QWY32XDICLOFENAC SODIUM AND MISOPROSTOL TABLET, DELAYED RELEASE [BRYANT RANCH PREPACK]1001
POVIDONE K30INACTIVE INGREDIENTU725QWY32XOXCARBAZEPINE TABLET, FILM COATED [BRYANT RANCH PREPACK]1001
POVIDONE K30INACTIVE INGREDIENTU725QWY32XTHEOPHYLLINE TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK]1001
POVIDONE K30INACTIVE INGREDIENTU725QWY32XVENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK]1001
POVIDONE K30INACTIVE INGREDIENTU725QWY32XATOVAQUONE AND PROGUANIL HCL (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE) TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
POVIDONE K30INACTIVE INGREDIENTU725QWY32XBENAZEPRIL HYDROCHLORIDE TABLET, COATED [BRYANT RANCH PREPACK]1000
POVIDONE K30INACTIVE INGREDIENTU725QWY32XBICALUTAMIDE TABLET [BRYANT RANCH PREPACK]1000
POVIDONE K30INACTIVE INGREDIENTU725QWY32XIMIPRAMINE HYDROCHLORIDE TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
POVIDONE K30INACTIVE INGREDIENTU725QWY32XPAROXETINE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000
POVIDONE K30INACTIVE INGREDIENTU725QWY32XPAROXETINE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000
POVIDONE K30INACTIVE INGREDIENTU725QWY32XPAROXETINE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000
POVIDONE K30INACTIVE INGREDIENTU725QWY32XPRAMIPEXOLE DIHYDROCHLORIDE TABLET [BRYANT RANCH PREPACK]1000
POVIDONE K30INACTIVE INGREDIENTU725QWY32XPRAMIPEXOLE DIHYDROCHLORIDE TABLET [BRYANT RANCH PREPACK]1000
POVIDONE K30INACTIVE INGREDIENTU725QWY32XTHEOPHYLLINE TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000
POVIDONE K30INACTIVE INGREDIENTU725QWY32XVENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000
POVIDONE K30INACTIVE INGREDIENTU725QWY32XETHAMBUTOL HYDROCHLORIDE (ETHAMBUTOL HYDROCHLORIDE) TABLET [REMEDYREPACK INC. ]84
povidone k30INACTIVE INGREDIENTU725QWY32XTAMIFLU (OSELTAMIVIR PHOSPHATE) POWDER, FOR SUSPENSION TAMIFLU (OSELTAMIVIR PHOSPHATE) CAPSULE [GENENTECH, INC.]30
POVIDONE K30INACTIVE INGREDIENTU725QWY32XPRAVASTATIN SODIUM TABLET [INTERNATIONAL LABORATORIES, INC.]26
POVIDONE K30INACTIVE INGREDIENTU725QWY32XEXJADE (DEFERASIROX) TABLET, FOR SUSPENSION [NOVARTIS PHARMACEUTICALS CORPORATION]24
POVIDONE K30INACTIVE INGREDIENTU725QWY32XDICLOFENAC SODIUM AND MISOPROSTOL TABLET, DELAYED RELEASE [ACTAVIS PHARMA, INC.]22
POVIDONE K30INACTIVE INGREDIENTU725QWY32XARTHROTEC (DICLOFENAC SODIUM AND MISOPROSTOL) TABLET, FILM COATED [G.D. SEARLE LLC DIVISION OF PFIZER INC]21
POVIDONE K30INACTIVE INGREDIENTU725QWY32XCLOZAPINE TABLET [TEVA PHARMACEUTICALS USA INC]20
POVIDONE K30INACTIVE INGREDIENTU725QWY32XLAMOTRIGINE TABLET [TEVA PHARMACEUTICALS USA INC]20
Povidone K30INACTIVE INGREDIENTU725QWY32XLEXIVA (FOSAMPRENAVIR CALCIUM) TABLET, FILM COATED LEXIVA (FOSAMPRENAVIR CALCIUM) SUSPENSION [VIIV HEALTHCARE COMPANY]19